Free Trial

Crinetics Pharmaceuticals (CRNX) Short Interest Ratio & Short Volume

Crinetics Pharmaceuticals logo
$33.39 +0.08 (+0.24%)
As of 04/30/2025 04:00 PM Eastern

Crinetics Pharmaceuticals Short Interest Data

Crinetics Pharmaceuticals (CRNX) has a short interest of 9.63 million shares, representing 11.05% of the float (the number of shares available for trading by the public). This marks a 12.76% increase in short interest from the previous month. The short interest ratio (days to cover) is 9.6, indicating that it would take 9.6 days of the average trading volume of 861,115 shares to cover all short positions.

Current Short Interest
9,630,000 shares
Previous Short Interest
8,540,000 shares
Change Vs. Previous Month
+12.76%
Dollar Volume Sold Short
$285.63 million
Short Interest Ratio
9.6 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
93,629,000 shares
Short Percent of Float
11.05%
Today's Trading Volume
662,955 shares
Average Trading Volume
861,115 shares
Today's Volume Vs. Average
77%
Short Selling Crinetics Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Crinetics Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CRNX Short Interest Over Time

CRNX Days to Cover Over Time

CRNX Percentage of Float Shorted Over Time

Crinetics Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/20259,630,000 shares $285.63 million +12.8%11.0%9.6 $29.66
3/31/20258,540,000 shares $286.43 million +9.9%9.8%7.8 $33.54
3/15/20257,770,000 shares $267.83 million -4.2%8.9%7.9 $34.47
2/28/20258,110,000 shares $290.18 million +4.0%9.3%8.6 $35.78
2/15/20257,800,000 shares $274.64 million +5.7%8.9%9.1 $35.21
1/31/20257,380,000 shares $297.41 million +2.9%N/A8.7 $40.30
1/15/20257,170,000 shares $263.35 million +3.6%N/A8.9 $36.73
12/31/20246,920,000 shares $353.82 million +10.7%N/A8.9 $51.13
12/15/20246,250,000 shares $335.38 million +4.0%N/A8.4 $53.66
11/30/20246,010,000 shares $343.77 million -7.5%N/A8.4 $57.20
11/15/20246,500,000 shares $355.68 million -6.3%N/A9.1 $54.72
10/31/20246,940,000 shares $388.36 million +5.3%N/A10.5 $55.96
10/15/20246,590,000 shares $379.58 million -2.8%N/A9.8 $57.60
9/30/20246,780,000 shares $346.46 million +11.0%N/A10.3 $51.10
9/15/20246,110,000 shares $328.72 million -1.8%N/A8.2 $53.80
8/31/20246,220,000 shares $330.03 million -3.9%N/A8.3 $53.06
8/15/20246,470,000 shares $339.87 million +5.7%N/A8 $52.53
7/31/20246,120,000 shares $325.09 million -7.0%N/A6.6 $53.12
7/15/20246,580,000 shares $356.24 million +12.1%N/A7 $54.14
6/30/20245,870,000 shares $262.92 million +0.2%N/A6.5 $44.79
6/15/20245,860,000 shares $265.63 million +16.5%N/A6.7 $45.33
5/31/20245,030,000 shares $223.38 million +2.4%N/A5.6 $44.41
5/15/20244,910,000 shares $247.91 million No ChangeN/A5.5 $50.49
4/30/20244,910,000 shares $215.16 million -5.9%N/A5.9 $43.82
4/15/20245,220,000 shares $228.01 million +6.3%N/A6.5 $43.68
3/31/20244,910,000 shares $229.84 million -2.0%N/A6.1 $46.81
3/15/20245,010,000 shares $195.04 million +5.7%N/A6.7 $38.93
2/29/20244,740,000 shares $194.06 million +5.1%N/A6 $40.94
2/15/20244,510,000 shares $166.51 million -11.1%N/A5.8 $36.92
1/31/20245,070,000 shares $184.95 million -0.8%N/A6.2 $36.48
1/15/20245,110,000 shares $190.04 million -0.6%N/A6 $37.19
12/31/20235,140,000 shares $182.88 million -13.6%N/A5.9 $35.58
12/15/20235,950,000 shares $205.04 million -6.7%N/A6.4 $34.46
11/30/20236,380,000 shares $202.82 million +2.9%N/A4 $31.79
11/15/20236,200,000 shares $179.06 million -7.6%N/A4 $28.88
10/31/20236,710,000 shares $196.54 million -1.5%N/A4.4 $29.29
10/15/20236,810,000 shares $198.24 million +16.4%N/A4.7 $29.11
9/30/20235,850,000 shares $173.98 million +43.7%N/A4.1 $29.74
9/15/20234,070,000 shares $120.02 million -10.4%N/A3.1 $29.49
8/31/20234,540,000 shares $78.63 million +21.4%N/A5.2 $17.32
Donald Trump is about to free crypto from its chains … (Ad)

Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .… Now Juan believes it could hit $150,000 … or higher in 2025.

There's another coin he thinks could do even better.
8/15/20233,740,000 shares $62.53 million +11.0%N/A7.9 $16.72
7/31/20233,370,000 shares $64.03 million -2.9%N/A7.2 $19.00
7/15/20233,470,000 shares $70.68 million +1.5%N/A7.2 $20.37
6/30/20233,420,000 shares $61.63 million +4.0%N/A7.6 $18.02
6/15/20233,290,000 shares $68.33 million No ChangeN/A7 $20.77
5/31/20233,290,000 shares $71.82 million -4.4%N/A7.2 $21.83
5/15/20233,440,000 shares $76.82 million -18.9%N/A7.7 $22.33
4/30/20234,240,000 shares $82.85 million -1.2%N/A9.9 $19.54
4/15/20234,290,000 shares $68.34 million -6.3%N/A10.6 $15.93
3/31/20234,580,000 shares $73.55 million +12.3%N/A10.8 $16.06
3/15/20234,080,000 shares $70.14 million +12.1%N/A10.1 $17.19
2/28/20233,640,000 shares $71.49 million +7.4%N/A8.9 $19.64
2/15/20233,390,000 shares $67.70 million -4.0%N/A8.8 $19.97
1/31/20233,530,000 shares $69.22 million -5.4%N/A9.3 $19.61
1/15/20233,730,000 shares $67.29 million No ChangeN/A11.1 $18.04
12/30/20223,730,000 shares $68.26 million +3.3%N/A11.7 $18.30
12/15/20223,610,000 shares $58.63 million -5.3%N/A12.1 $16.24
11/30/20223,810,000 shares $68.08 million -1.3%N/A14.3 $17.87
11/15/20223,860,000 shares $70.41 million -3.7%N/A14.3 $18.24
10/31/20224,010,000 shares $74.02 million -1.7%N/A14.4 $18.46
10/15/20224,080,000 shares $72.05 million +1.5%N/A15 $17.66
9/30/20224,020,000 shares $78.95 million +3.1%N/A15.6 $19.64
9/15/20223,900,000 shares $83.34 million +9.9%N/A14 $21.37
8/31/20223,550,000 shares $67.02 million +13.4%N/A12.3 $18.88
8/15/20223,130,000 shares $70.02 million +12.6%N/A10.3 $22.37
7/31/20222,780,000 shares $53.40 million -2.1%N/A8.9 $19.21
7/15/20222,840,000 shares $58.82 million -1.1%N/A9 $20.71
6/30/20222,870,000 shares $53.53 million +5.9%N/A8.3 $18.65
6/15/20222,710,000 shares $47.86 million +8.8%N/A7.4 $17.66
5/31/20222,490,000 shares $41.71 million +2.1%N/A7.5 $16.75
5/15/20222,440,000 shares $45.75 million +11.9%N/A7.9 $18.75
4/30/20222,180,000 shares $44.30 million -18.1%N/A7.9 $20.32
4/15/20222,660,000 shares $69.16 million +0.8%N/A9.5 $26.00
3/31/20222,640,000 shares $57.95 million +13.3%N/A10.7 $21.95
3/15/20222,330,000 shares $44.46 million +10.4%6.2%9.6 $19.08
2/28/20222,110,000 shares $42.24 million +0.5%5.6%8.1 $20.02
2/15/20222,100,000 shares $41.43 million +23.5%5.6%7.6 $19.73
1/31/20221,700,000 shares $32.11 million +39.3%N/A6.1 $18.89
1/15/20221,220,000 shares $29.29 million -6.9%N/A4.3 $24.01
12/31/20211,310,000 shares $37.22 million +12.0%N/A4.1 $28.41
12/15/20211,170,000 shares $29.45 million +18.1%N/A3.8 $25.17
11/30/2021990,900 shares $27.07 million -1.9%N/A3.6 $27.32
11/15/20211,010,000 shares $27.26 million -13.7%N/A3.8 $26.99
10/29/20211,170,000 shares $29.17 million -17.0%3.4%4.4 $24.93
10/15/20211,410,000 shares $27.48 million -4.7%4.8%5.7 $19.49
9/30/20211,480,000 shares $31.15 million +16.5%5.0%8.5 $21.05
9/15/20211,270,000 shares $29.85 million -3.1%4.3%6.7 $23.50
8/31/20211,310,000 shares $30.88 million +5.7%4.7%6.7 $23.57
8/13/20211,240,000 shares $27.60 million -4.6%4.4%6.3 $22.26
7/30/20211,300,000 shares $23.37 million -0.8%4.9%7.8 $17.98
Donald Trump is about to free crypto from its chains … (Ad)

Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .… Now Juan believes it could hit $150,000 … or higher in 2025.

There's another coin he thinks could do even better.
7/15/20211,310,000 shares $25.82 million -3.7%4.5%8.2 $19.71
6/30/20211,360,000 shares $25.64 million +2.3%4.7%7.9 $18.85
6/15/20211,330,000 shares $24.25 million -8.3%4.6%7.9 $18.23
5/28/20211,450,000 shares $25.45 million -4.6%5.0%10.2 $17.55
5/14/20211,520,000 shares $24.17 million -0.7%N/A12 $15.90
4/30/20211,530,000 shares $27.17 million -0.7%N/A11.1 $17.76
4/15/20211,540,000 shares $25.29 million +2.0%N/A11.1 $16.42
3/31/20211,510,000 shares $23.31 million -2.6%N/A11 $15.44
3/15/20211,550,000 shares $26.24 million +1.3%N/A11.1 $16.93
2/26/20211,530,000 shares $23.03 million +10.9%N/A11.2 $15.05
2/12/20211,380,000 shares $23.78 million -7.4%N/A9 $17.23
1/29/20211,490,000 shares $22.22 million +2.1%N/A9.5 $14.91
1/15/20211,460,000 shares $21.58 million +1.4%N/A8.3 $14.78
12/31/20201,440,000 shares $19.71 million +9.9%N/A8.2 $13.69
12/15/20201,310,000 shares $17.99 million +0.8%N/A8.1 $13.73
11/30/20201,300,000 shares $18.67 million +3.2%N/A8.8 $14.36
11/15/20201,260,000 shares $16.23 million +7.7%N/A9.1 $12.88
10/30/20201,170,000 shares $14.60 million -14.6%N/A9.9 $12.48
10/15/20201,370,000 shares $22.15 million -3.5%N/A13.2 $16.17
9/30/20201,420,000 shares $22.25 million +2.2%N/A14.3 $15.67
9/15/20201,390,000 shares $22.27 million -3.5%N/A8.7 $16.02
8/31/20201,440,000 shares $23.08 million -0.7%N/A7.6 $16.03
8/14/20201,450,000 shares $22.05 million -2.7%N/A7.1 $15.21
7/31/20201,490,000 shares $20.68 million -15.8%N/A6.8 $13.88
7/15/20201,770,000 shares $26.92 million -30.3%N/A8.1 $15.21
6/30/20202,540,000 shares $45.42 million +84.1%10.6%10.4 $17.88
6/15/20201,380,000 shares $23.54 million No Change5.7%7.2 $17.06
5/29/20201,380,000 shares $22.55 million +3.0%5.8%8.7 $16.34
5/15/20201,340,000 shares $26.40 million -11.3%N/A9.8 $19.70

CRNX Short Interest - Frequently Asked Questions

What is Crinetics Pharmaceuticals' current short interest?

Short interest is the volume of Crinetics Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 9,630,000 shares of CRNX short. 11.05% of Crinetics Pharmaceuticals' shares are currently sold short. Learn More on Crinetics Pharmaceuticals' current short interest.

What is a good short interest ratio for Crinetics Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRNX shares currently have a short interest ratio of 10.0. Learn More on Crinetics Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Crinetics Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Crinetics Pharmaceuticals: Citadel Advisors LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Crinetics Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.05% of Crinetics Pharmaceuticals' floating shares are currently sold short.

Is Crinetics Pharmaceuticals' short interest increasing or decreasing?

Crinetics Pharmaceuticals saw a increase in short interest in April. As of April 15th, there was short interest totaling 9,630,000 shares, an increase of 12.8% from the previous total of 8,540,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Crinetics Pharmaceuticals' short interest compare to its competitors?

11.05% of Crinetics Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Crinetics Pharmaceuticals: Dr. Reddy's Laboratories Limited (1.91%), Moderna, Inc. (16.48%), Ascendis Pharma A/S (11.37%), Viatris Inc. (3.96%), Qiagen (2.11%), Roivant Sciences Ltd. (11.68%), Revolution Medicines, Inc. (10.62%), Lantheus Holdings, Inc. (10.23%), BridgeBio Pharma, Inc. (15.57%), TG Therapeutics, Inc. (16.90%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short Crinetics Pharmaceuticals stock?

Short selling CRNX is an investing strategy that aims to generate trading profit from Crinetics Pharmaceuticals as its price is falling. CRNX shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Crinetics Pharmaceuticals?

A short squeeze for Crinetics Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CRNX, which in turn drives the price of the stock up even further.

How often is Crinetics Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRNX, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:CRNX) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners